Zafgen appoints Dennis Kim CMO
This article was originally published in Scrip
Zafgen, a pharmaceutical company developing novel obesity therapeutics, has named Dr Dennis Kim chief medical officer. Dr Kim is an endocrinologist with over 10 years' experience in the biotech and medical technology industries. He most recently served at Orexigen Therapeutics in multiple senior roles, including senior vice-president and head of obesity/metabolic diseases.